AI assistant
Sending…
Atea Pharmaceuticals, Inc. — Director's Dealing 2024
Jun 8, 2024
33577_dirs_2024-06-07_9fdd7902-e272-4ada-8822-e7868e8ceafa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Atea Pharmaceuticals, Inc. (AVIR)
CIK: 0001593899
Period of Report: 2024-06-05
Reporting Person: Sommadossi Jean-Pierre (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-06-05 | Common Stock | S | 1006 | $4.00 | Disposed | 5923994 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 116557 | Direct |
More from Atea Pharmaceuticals, Inc.
Proxy Solicitation & Information Statement
2026
Apr 27
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Director's Dealing
2026
Feb 3
Regulatory Filings
2026
Jan 8
Major Shareholding Notification
2025
Dec 5